AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 1 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,037,000 | +5.3% | 440,923 | -35.7% | 0.00% | 0.0% |
| Q2 2020 | $1,934,000 | +69.4% | 685,923 | +46.5% | 0.00% | +100.0% |
| Q1 2020 | $1,142,000 | -30.4% | 468,123 | +46.1% | 0.00% | 0.0% |
| Q4 2019 | $1,641,000 | -8.6% | 320,423 | +15.3% | 0.00% | -50.0% |
| Q3 2019 | $1,796,000 | -12.6% | 278,023 | -15.7% | 0.00% | 0.0% |
| Q2 2019 | $2,055,000 | – | 329,823 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |